US biotech Lunai Bioworks (Nasdaq: LNAI) has signed its first letter of intent to license its off-the-shelf immune cell ...

Danish drugmaker Novo Nordisk (NOV: N) has asked the US Food and Drug Administration regulator to assess a stronger 7.2 mg ...

US biotech Kura Oncology (Nasdaq: KURA) and Japanese specialty pharma Kyowa Kirin (TSE: 4151) have secured early guideline ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Swiss pharma giant Roche’s Itovebi ...

A public biotech company developing cell-encapsulation therapies using its live-cell encapsulation platform to treat cancer, ...

Further to the announcement under Rule 2.7 of the Irish Takeover Rules by Avadel and Alkermes on November 19, 2025, Danish ...

Australia’s Therapeutic Goods Administration (TGA) has issued a safety warning regarding the discontinuation of Prolia ...

The UK BioIndustry Association (BIA) has welcomed key measures in yesterday’s Autumn Budget that that broadly support the ...

A private, clinical-stage biopharma company developing small-molecule–based therapies administered directly to treat ...

The US regulator has reported a sharp rise in expected savings after completing its second round of Medicare drug price ...

The American medicines regulator has approved a reformulated version of ranitidine from USA-based VKT Pharma, restoring the ...

India’s Sun Pharmaceutical Industries today announced the US Food and Drug Administration (FDA) approved an updated label for ...